Restructuring Expenses	12 Months Ended
Jun. 30, 2026
Restructuring and Related Activities [Abstract]
Restructuring Expenses	Restructuring Expenses Restructuring expenses consist of costs incurred in connection with the realignment of business strategies and operations as well as cost rationalization efforts. These costs are separately presented as restructuring expenses within our consolidated statement of income for all periods presented. Although the costs associated with restructuring plans have not been allocated to our business segments' results in Note 13 – Segment Information, the restructuring plans impacted both our Sleep and Breathing Health and Residential Care Software segments. During the year ended June 30, 2026, we recorded $22 million of restructuring related charges for employee severance and one-time termination benefits associated with workforce planning activities. These costs are separately presented as restructuring expenses within our condensed consolidated statement of operations. We had $1 million remaining in our accruals at June 30, 2026. We do not expect any remaining expense under existing one-time termination benefit arrangements to be material. We did not incur material restructuring expenses during the year ended June 30, 2025. During the year ended June 30, 2024, we recorded $64 million of restructuring related charges associated with an evaluation of our existing operations to increase operational efficiency, decrease costs and increase profitability. Restructuring charges for the year ended June 30, 2024 were comprised of $29 million of employee severance and other one-time termination benefits, $33 million of intangible asset impairments associated with the wind down of certain business activities, and $2 million of other miscellaneous asset impairments. As of June 30, 2024, there were no restructuring expenses remaining in our accruals.

Restructuring Expenses

12 Months Ended

Jun. 30, 2026

Restructuring and Related Activities [Abstract]

Restructuring expenses consist of costs incurred in connection with the realignment of business strategies and operations as well as cost rationalization efforts. These costs are separately presented as restructuring expenses within our consolidated statement of income for all periods presented. Although the costs associated with restructuring plans have not been allocated to our business segments' results in Note 13 – Segment Information, the restructuring plans impacted both our Sleep and Breathing Health and Residential Care Software segments.

During the year ended June 30, 2026, we recorded $22 million of restructuring related charges for employee severance and one-time termination benefits associated with workforce planning activities. These costs are separately presented as restructuring expenses within our condensed consolidated statement of operations. We had $1 million remaining in our accruals at June 30, 2026. We do not expect any remaining expense under existing one-time termination benefit arrangements to be material.

We did not incur material restructuring expenses during the year ended June 30, 2025.

During the year ended June 30, 2024, we recorded $64 million of restructuring related charges associated with an evaluation of our existing operations to increase operational efficiency, decrease costs and increase profitability. Restructuring charges for the year ended June 30, 2024 were comprised of $29 million of employee severance and other one-time termination benefits, $33 million of intangible asset impairments associated with the wind down of certain business activities, and $2 million of other miscellaneous asset impairments. As of June 30, 2024, there were no restructuring expenses remaining in our accruals.